Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul-Aug;76(4):260-267.
doi: 10.1016/j.ihj.2024.07.002. Epub 2024 Jul 14.

Results of comprehensive genetic testing in patients presenting to a multidisciplinary inherited heart disease clinic in India

Priya Chockalingam  1 , Thenral S Geetha  2 , Sandhya Nair  3 , Nivedita Rajakumar  4 , Deep Chandh Raja  5 , Yash Lokhandwala  6 , Vivek Chaturvedi  7 , Raja J Selvaraj  8 , Sakthivel Ramasamy  9 , Sheetal Sharda  10 , C Sundar  11 , R Anantharaman  12
Affiliations

Results of comprehensive genetic testing in patients presenting to a multidisciplinary inherited heart disease clinic in India

Priya Chockalingam et al. Indian Heart J. 2024 Jul-Aug.

Abstract

Objectives: This study aims to analyze the results of comprehensive genetic testing in patients presenting to a dedicated multidisciplinary inherited heart disease clinic in India.

Methods: All patients presenting to our clinic from August 2017 to October 2023 with a suspected inherited heart disease and consenting for genetic testing were included. The probands were grouped into familial cardiomyopathies namely hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), arrhythmogenic cardiomyopathy (ACM) and peripartum cardiomyopathy (PPCM), channelopathies namely congenital long QT syndrome (LQTS) and Brugada syndrome (BrS), and heritable connective tissue disorder namely Marfan Syndrome (MFS). Next generation sequencing (NGS) was used, and pre-test and post-test counseling were provided to probands and cascade screening offered to relatives.

Results: Mean age of the subjects (n = 77; 48 probands, 29 relatives) was 43 ± 18 years, 68 % male and 44 % symptomatic, with 36 HCM, 3 DCM, 3 ACM, 1 PPCM, 3 LQTS, 1 BrS and 1 MFS probands. The diagnostic yield of NGS-based genetic testing was 31 %; variants of uncertain significance (VUS) were identified in 54 %; and 15 % were genotype-negative. Twenty-nine relatives from 18 families with HCM (n = 12), DCM (n = 3), ACM (n = 2) and MFS (n = 1) underwent genetic testing. The genotype positive probands/relatives and VUS carriers with strong disease phenotype and/or high risk variant were advised periodic follow-up; the remaining probands/relatives were discharged from further clinical surveillance.

Conclusions: Genetic testing guides treatment and follow-up of patients with inherited heart diseases and should be carried out in dedicated multidisciplinary clinics with expertise for counseling and cascade screening of family members.

Keywords: Cardiomyopathies; Channelopathies; Genetic testing; Multidisciplinary clinic; Sudden cardiac death prevention.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Distribution of diseases in the probands.
Fig. 2
Fig. 2
Panel A. Results of genetic testing in the probands Fig. 2 Panel B. Genes harboring mutations in the HCM probands.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • Cardiogenetics: Closing the knowledge gap in India.
    Chockalingam P, Wilde AAM. Chockalingam P, et al. Indian Pacing Electrophysiol J. 2025 May-Jun;25(3):175-176. doi: 10.1016/j.ipej.2025.05.006. Epub 2025 May 26. Indian Pacing Electrophysiol J. 2025. PMID: 40436343 Free PMC article. No abstract available.

References

    1. Stiles M.K., Wilde A.A.M., Abrams D.J., et al. 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families. Heart Rhythm. 2021;18:e1–e50. - PMC - PubMed
    1. Guo L., Torii S., Fernandez R., et al. Genetic variants associated with unexplained sudden cardiac death in Adult white and African American individuals. JAMA Cardiol. 2021;6:1013–1022. - PMC - PubMed
    1. Wilde A.A.M., Nannenberg E. van der Werf C. Cardiogenetics, 25 years a growing subspecialism. Neth Heart J. 2020;28:39–43. - PMC - PubMed
    1. Wilde A.A.M., Semsarian C., Márquez M.F., et al. Expert Consensus Statement on the state of genetic testing for cardiac diseases. EP Europace. August 2022;24(Issue 8):1307–1367. - PMC - PubMed
    1. Maron B.J., Kalra A. Hypertrophic cardiomyopathy in the developing world: focus on India. Eur Heart J. 2014;35:2492–2495. - PubMed